[Influence of hepatotropic carcinogens upon a ribosomal ferritin fraction].
D000085:Acetates / Q000494:pharmacology*; D000577:Amides / Q000494:pharmacology*; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic; D004589:Electrophoresis, Disc; D005293:Ferritins / Q000378:metabolism*; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D008113:Liver Neoplasms / Q000209:etiology; D009025:Morpholines / Q000494:pharmacology*; D009602:Nitrosamines / Q000494:pharmacology*; D009603:Nitroso Compounds / Q000494:pharmacology*; D011230:Precancerous Conditions; D051381:Rats; D012270:Ribosomes / Q000187:drug effects / Q000378:metabolism*
D000085:Acetates; D000577:Amides; D002273:Carcinogens; D009025:Morpholines; D009602:Nitrosamines; D009603:Nitroso Compounds; D005293:Ferritins
Beeinsflussung einer ribosomalen Ferritin-Fraktion durch hepatotrope Carcinogene.